Jason Bennett, MD
Urogynecology and Reconstructive Pelvic Surgery · Grand Rapids, MINPI 1295757631
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $50,850 of the $67,891 with a category attached, or 74.9%. Philips North America LLC accounts for 88.6% of it on its own, with 22 other manufacturers making up the rest. Among urogynecology and reconstructive pelvic surgery clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $337.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$60K
- Medtronic$3K
- Axonics, Inc.$2K
- Momentis Surgical Inc.$812
- AbbVie$522
- Medical Device Business Services, Inc.$287
- plus $1K from 17 others
Across 28 payments — averaging $1360.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$36K
- Cook Research Incorporated$2K
What the payments were for
- Consulting fees$2,1703%
- Speaking & faculty fees$50,85075%
- Travel & lodging$11,27217%
- Food & beverage$3,4495%
- Education$230%
- Gifts$1270%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 62 | $60,179 |
| Medtronic(2 entities) | 45 | $3,420 |
| Axonics, Inc. | 18 | $1,540 |
| Momentis Surgical Inc. | 3 | $812 |
| AbbVie(2 entities) | 22 | $522 |
| Medical Device Business Services, Inc. | 5 | $287 |
| Coloplast | 8 | $200 |
| Astellas Pharma US Inc | 8 | $166 |
| Intuitive Surgical | 2 | $127 |
| Sumitomo Pharma America, Inc. | 8 | $127 |
| Caldera Medical, Inc | 2 | $110 |
| Femselect Inc. | 2 | $102 |
| Urovant Sciences Inc | 2 | $52 |
| Valencia Technologies Corporation | 2 | $48 |
| Integra Lifesciences Corporation | 2 | $45 |
| Laborie Medical Technologies Corp. | 2 | $42 |
| AMAG Pharmaceuticals, Inc. | 2 | $23 |
| Avation Medical, Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Coopersurgical, Inc. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
| Boston Scientific | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (1658) Clinical Educ Ultrasound$38,195
- Educ Ultrasound$20,292
- Axonics$1,059
- Clin Educ US$854
- Anovo Surgical System$812
- Bulkamid$121
- INTERSTIM$112
How this compares
$67,891 in reported general payments places this provider in the 95th percentile of 33 urogynecology and reconstructive pelvic surgery providers in Michigan.
See all urogynecology and reconstructive pelvic surgery providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 76 | $55,414 |
| GemtesaVibegron | 18 | $17,560 |
| Estradiol | 94 | $10,296 |
| Trospium Chloride ErTrospium Chloride | 50 | $9,160 |
| Trospium Chloride | 46 | $2,301 |
| YuvafemEstradiol | 11 | $1,856 |
| Methenamine Hippurate | 11 | $1,654 |
| Nystatin | 70 | $768 |
| Metronidazole | 23 | $710 |
| Solifenacin Succinate | 11 | $573 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 110 | $430 |
| Cefdinir | 11 | $271 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 120 | $253 |
| Cephalexin | 66 | $210 |
| Ibuprofen | 57 | $145 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $166 | $55,41476 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $127 | $17,56018 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 33 urogynecology and reconstructive pelvic surgery providers in Michigan.
Other urogynecology and reconstructive pelvic surgery in Grand Rapids
- Hope BauerGrand Rapids$5K
- Deslyn HobsonGrand Rapids$3K
- Mallorie HooverGrand Rapids$1K
- Shefali SharmaGrand Rapids$413
- Raisa PlatteGrand Rapids$208
- Michael BennettGrand Rapids$203
- Jannah ThompsonNorton Shores$474K
- Priyanka GuptaAnn Arbor$39K
- Jason CruffDearborn$12K
- John DelanceyAnn Arbor$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.